Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare ConferenceSAN FRANCISCO and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the Jefferies Global Healthcare Conference, June 3-5, 2025, in New York.
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach SummitVANCOUVER, British Columbia and SAN FRANCISCO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in two upcoming investor conferences in March 2025:
Jade Biosciences to Participate in Upcoming Investor ConferencesVANCOUVER, British Columbia and SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Jade Biosciences (“Jade”), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced that the company will participate in two upcoming investor conferences in November 2024.
Aerovate Therapeutics and Jade Biosciences Announce Merger AgreementMerger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases
